Esperovax and Ginkgo Bioworks Announce Partnership to Develop Circular RNA-based Therapeutics
Initial focus of partnership will aim to develop cancer therapeutics PLYMOUTH, Mich. and BOSTON, Jan. 5, 2023 /PRNewswire/ — Esperovax, an innovative developer of oral mRNA biologics, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and…
Comments Off on Esperovax and Ginkgo Bioworks Announce Partnership to Develop Circular RNA-based Therapeutics